These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26449578)

  • 1. [Shiga toxin and tetanus toxin as a potential biologic weapon].
    Toczyska I; Płusa T
    Pol Merkur Lekarski; 2015 Sep; 39(231):157-61. PubMed ID: 26449578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Differentiation of Shiga Toxin-Associated Hemolytic Uremic Syndrome in Critically Ill Adults With Thrombotic Microangiopathy Syndromes.
    Joseph A; Rafat C; Zafrani L; Mariani-Kurkdjian P; Veyradier A; Hertig A; Rondeau E; Mariotte E; Azoulay E
    Crit Care Med; 2018 Sep; 46(9):e904-e911. PubMed ID: 29979220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin-Mediated Hemolytic Uremic Syndrome.
    Beneke J; Sartison A; Kielstein JT; Haller H; Nitschke M; Kunzendorf U; Loos S; Kemper MJ; Stahl RA; Menne J;
    Transfus Med Rev; 2017 Jan; 31(1):51-55. PubMed ID: 27468945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Wada H; Matsumoto T; Yamashita Y
    Semin Thromb Hemost; 2014 Nov; 40(8):866-73. PubMed ID: 25377323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.
    Tarr PI; Gordon CA; Chandler WL
    Lancet; 2005 Mar 19-25; 365(9464):1073-86. PubMed ID: 15781103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post-diarrheal haemolytic uremic syndrome: when shall we consider it? Which follow-up?].
    Bertholet-Thomas A; Ranchin B; King LA; Bacchetta J; Belot A; Gillet Y; Collardeau-Frachon S; Cochat P
    Arch Pediatr; 2011 Jul; 18(7):823-30. PubMed ID: 21571510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-infection in children with bloody diarrhea caused by Shiga toxin-producing Escherichia coli: data of the North Italian HUS Network.
    Ardissino G; Possenti I; Salardi S; Tel F; Colombo E; Testa S; Daprai L; Picicco D; Colombo RM; Torresani E
    J Pediatr Gastroenterol Nutr; 2014 Aug; 59(2):218-20. PubMed ID: 24824362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.
    Joseph A; Cointe A; Mariani Kurkdjian P; Rafat C; Hertig A
    Toxins (Basel); 2020 Jan; 12(2):. PubMed ID: 31973203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome.
    Braune SA; Wichmann D; von Heinz MC; Nierhaus A; Becker H; Meyer TN; Meyer GP; Müller-Schulz M; Fricke J; de Weerth A; Hoepker WW; Fiehler J; Magnus T; Gerloff C; Panzer U; Stahl RA; Wegscheider K; Kluge S
    Crit Care Med; 2013 Jul; 41(7):1702-10. PubMed ID: 23660733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy for children with Shiga toxin-E. coli-associated hemolytic uremic syndrome].
    Ito K; Hattori M; Matsumoto N
    Nihon Rinsho; 2002 Jun; 60(6):1126-30. PubMed ID: 12078084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga Toxin Therapeutics: Beyond Neutralization.
    Hall G; Kurosawa S; Stearns-Kurosawa DJ
    Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28925976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
    Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shiga toxin-producing Escherichia coli infection.
    Thorpe CM
    Clin Infect Dis; 2004 May; 38(9):1298-303. PubMed ID: 15127344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Southwestern Internal Medicine Conference: Shiga-like toxins in hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura.
    Hofmann SL
    Am J Med Sci; 1993 Dec; 306(6):398-406. PubMed ID: 8266983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2.
    Ibarra C; Amaral MM; Palermo MS
    IUBMB Life; 2013 Oct; 65(10):827-35. PubMed ID: 24014500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evidence based treatment for Shiga-toxin-producing E. coli related hemolytic uremic syndrome].
    Ito S
    Nihon Jinzo Gakkai Shi; 2014; 56(7):1075-81. PubMed ID: 25420408
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemolytic uremic syndrome caused by enterohaemorrhagic Escherichia coli].
    Ibarra C; Goldstein J; Silberstein C; Zotta E; Belardo M; Repetto HA
    Arch Argent Pediatr; 2008 Oct; 106(5):435-42. PubMed ID: 19030644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.
    Ray PE; Liu XH
    Pediatr Nephrol; 2001 Oct; 16(10):823-39. PubMed ID: 11605791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock.
    Valles PG; Pesle S; Piovano L; Davila E; Peralta M; Principi I; Lo Giudice P
    Medicina (B Aires); 2005; 65(5):395-401. PubMed ID: 16296634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.